From hazard identification to weighing the benefits and drawbacks of prevention

Toxicology and Applied Pharmacology

Volumn 207, Issue 2 SUPPL., 2005, Pages 28-33

  Vainio, Harri ^a   Weiderpass, Elisabete ^b,c  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer screening; Cancer prevention; Cancer risk

Indexed keywords

ACETYLSALICYLIC ACID; CARCINOGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CARCINOMA IN SITU; CARDIOVASCULAR DISEASE; CATARACT; CHEMOPROPHYLAXIS; CLASSIFICATION; CLINICAL TRIAL; COLON CANCER; COMPARATIVE STUDY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SCREENING; ENDOMETRIUM CANCER; FOOD INTAKE; FOREARM FRACTURE; FRUIT; GENETIC PREDISPOSITION; HAZARD ASSESSMENT; HEALTH CARE POLICY; HEALTH PROGRAM; HIP FRACTURE; HUMAN; INTERNATIONAL COOPERATION; LIFESTYLE; LUNG EMBOLISM; MAMMOGRAPHY; MEDICAL LITERATURE; PHYSICAL ACTIVITY; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RISK BENEFIT ANALYSIS; SIDE EFFECT; SPINE FRACTURE; STROKE; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES; UTERINE CERVIX CANCER; VEGETABLE; WORLD HEALTH ORGANIZATION;

EID: 24644508566     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.03.030     Document Type: Conference Paper

References (13)

1. A.L. Barratt, M. Les Irwig, P.P. Glasziou, G.P. Salkeld, and N. Houssami Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review Med. J. Aust. 176 2002 247 248
2. N.E. Day, S.D. Walter, L. Tabar, C.J.B. Fagerberg, and H.J.A. Collette The sensitivity and lead time of breast cancer screening: a comparison of the results of different studies N.E. Day A.B. Miller Screening for Breast Cancer 1988 Hans Huber Toronto 105 110
3. R.S. Eidelman, P.R. Hebert, S.M. Weisman, and C.H. Hennekens An update on aspirin in the primary prevention of cardiovascular disease Arch. Intern. Med. 163 2003 2006 2010
4. B. Fisher, J.P. Costantino, D.L. Wickerham, C.K. Redmond, M. Kavanah, W.M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-Chiu, L. Ford, and N. Wolmark Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90 1998 1371 1388
5. S.W. Fletcher, W. Black, R. Harris, B.K. Rimer, and S. Shapiro Report of the International Workshop on Screening for Breast Cancer J. Natl. Cancer Inst. 85 1993 1644 1656
6. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Tobacco Smoking vol. 38 1986 IARC Press Lyon
7. IARC Handbooks of Cancer Prevention Breast Cancer Screening vol. 7 2002 IARC Press Lyon
8. IARC Handbooks of Cancer Prevention Weight Control and Physical Activity vol. 6 2002 IARC Press Lyon
9. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Tobacco Smoking and Involuntary Smoking vol. 83 2004 IARC Press Lyon
10. A.B. Miller, T. To, C.J. Baines, and C. Wall Canadian National Breast Screening Study-2: 13 year results of a randomized trial in women age 50-59 years J. Natl. Cancer Inst. 92 2000 1490 1499
11. R.J. Santen Risk of breast cancer with progestins-Critical assessment of current data Steroids 68 2003 953 964
12. M.B. Sporn Approaches to prevention of epithelial cancer during the preneoplastic period Cancer Res. 36 1976 2699 2702
13. US Preventive Task Force Report of the US Preventive Services Task Force, Guide to Clinical Preventive Services 2nd ed. 1996 Williams and Wilkins Baltimore 73 88